BIOA
HealthcareBioAge Labs, Inc.
$12.62
$-0.21 (-1.64%)
Jan 5, 2026
Price History (1Y)
Analysis
BioAge Labs, Inc. operates within the Healthcare sector and Drug Manufacturers - Specialty & Generic industry. With a market capitalization of $452.49 million, the company is considered relatively small-scale. BioAge Labs employs 62 individuals. Financially, BioAge Labs has reported negative profitability metrics, including a gross margin of -63.2%, operating margin of -1126.6%, and profit margin of 0.0%. The company's returns on equity and assets are also negative at -25.6% and -17.5%, respectively. On the balance sheet, BioAge Labs has relatively low debt with $7.13 million in liabilities compared to its $285.78 million cash reserves. BioAge Labs' valuation metrics indicate a significant discount, as reflected by a price-to-earnings ratio of 0.94 and forward P/E of -4.53. The company's enterprise value to EBITDA is also negative at -2.03. Notably, BioAge Labs does not pay dividends, with a payout ratio of 0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About BioAge Labs, Inc.
BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. It also provides azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.
Visit website →Key Statistics
- Market Cap
- $452.49M
- P/E Ratio
- 0.94
- 52-Week High
- $14.46
- 52-Week Low
- $2.88
- Avg Volume
- 455.57K
Company Info
- Exchange
- NMS
- Country
- United States
- Employees
- 62